Abstract:The imidazole based 1,2,3 triazole hybrids showed potential p38 MAP kinase anti‐inflammatory inhibitors. Compound 7 c, 7 f and 7 n were found to be most significant comparable to prototype drug Adezmapimod (7 f>7 c>7 n>Adezmapimod). The compound 7 f was the most active compound of the series concerning docking score, ADME studies, and in vitro p38 MAP kinase inhibitory activity. p38 MAP kinases are involved in numerous inflammatory diseases. A series of 14 molecules of 1,2,3 triazole linked 4‐((2‐cyclohexyl‐4,5‐diphenyl‐1H‐imidazol‐1‐yl) methyl)‐1‐phenyl hybrids(7 a–7 n) has been synthesized by click reaction. Spectral data characterized all the synthesized compounds. The final compounds were screened for in vitro p38 MAP kinase inhibitory activity. Three compounds from the series 7 c, 7 f, and 7 n expounded superior activity with IC50 values 234.08±19.65 nM, 222.68±20.69 nM, and 241.70±20.51 nM respectively while two compounds (7 d and 7 e) showed considerable activity compared to prototype drug Adezmapimod (SB203580) (IC50 value 257.13±23.94 nM). The docking study of synthesized molecules revealed that the three compounds (7 f,7 g, and 7 n) showed higher binding affinities than Adezmapimod. The "Desmond v3.6 Program" was utilized to conduct MD simulations. The result revealed that compound 7 f was conformationally stable. The ADME studies were performed using the Swiss ADME algorithm. Studies revealed that all the compound's defiance of Lipinski's rule is within acceptable ranges with few violations. Compound 7 f was orally active and showed good gastrointestinal absorption within the acceptable range. The search for newer compounds with increased activity compared to Adezmapimod resulted in identifying a novel subclass of p38 MAP kinase inhibitors.

Ligand-based 3D pharmacophore design, virtual screening and molecular docking for novel p38 MAPK inhibitors

Evaluation of the Combination Mode and Features of P38 MAPK Inhibitors: Construction of Different Pharmacophore Models and Molecular Docking

Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation

3d-Qsar And Molecular Docking Studies On Fused Pyrazoles As P38 Alpha Mitogen-Activated Protein Kinase Inhibitors

Docking and 3D-QSAR study on p38α MAP kinase inhibitors

Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives As P38 MAP Kinase Inhibitors by Computational Explorations

Novel Strategies for Inhibition of the P38 MAPK Pathway.

Binding Mechanism of Inhibitors to P38α MAP Kinase Deciphered by Using Multiple Replica Gaussian Accelerated Molecular Dynamics and Calculations of Binding Free Energies.

Molecular Dynamics Simulation and Free Energy Calculation Studies of the Binding Mechanism of Allosteric Inhibitors with P38α MAP Kinase.

Benzothiazole Based Inhibitors of P38α MAP Kinase

Recent Advance on P38 Mitogen-Activated Protein Kinases Inhibitors

Design, Synthesis, and Anti-Inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-f][1,2,4]triazine P38alpha Mitogen-Activated Protein Kinase Inhibitors.

Development of an online p38α mitogen-activated protein kinase binding assay and integration of LC–HR-MS

5-amino-pyrazoles as potent and selective p38α inhibitors.

Design, synthesis, biological evaluation, and in silico studies of quinoxaline derivatives as potent p38α MAPK inhibitors

Inhibition of Inflammation by a P38 MAP Kinase Targeted Cell Permeable Peptide

Applications of 3D-QSAR and Structure-Based Pharmacophore Modeling, Virtual Screening, ADMET, and Molecular Docking of Putative MAPKAP-K2 (MK2) Inhibitors

Design, Synthesis, in vitro Anti‐inflammatory Activity and in silico Studies of Imidazole‐Based 1,2,3‐Triazole Hybrids Targeting p38 MAP Kinase

A comparative study of fragment screening methods on the p38α kinase: new methods, new insights

P38 Mitogen‐activated Protein Kinase: Functions and Targeted Therapy in Diseases

Synthesis and biological assessment of triazolo-quinazoline carbothioamide derivatives for p38 MAP kinase inhibition: in-silico and in-vitro approaches